Modeling 1-year Relapse-free Survival After Neoadjuvant Chemotherapy and Radical Cystectomy in Patients with Clinical T2–4N0M0 Urothelial Bladder Carcinoma: Endpoints for Phase 2 Trials
- Marco Bandini
- , Alberto Briganti
- , Elizabeth R. Plimack
- , Günter Niegisch
- , Evan Y. Yu
- , Aristotelis Bamias
- , Neeraj Agarwal
- , Srikala S. Sridhar
- , Cora N. Sternberg
- , Ulka Vaishampayan
- , Christine Théodore
- , Jonathan E. Rosenberg
- , Joaquim Bellmunt
- , Matthew D. Galsky
- , Francesco Montorsi
- , Andrea Necchi
- Vita-Salute San Raffaele University
- Heinrich Heine University Düsseldorf
- University of Washington
- National and Kapodistrian University of Athens
- University of Utah
- Princess Margaret Cancer Centre
- San Camillo Hospital
- Wayne State University
- Hôpital Foch
- Memorial Sloan-Kettering Cancer Center
- Harvard University
- Icahn School of Medicine at Mount Sinai
- Fondazione IRCCS Istituto Nazionale dei Tumori
Research output: Contribution to journal › Article › peer-review
12
Scopus
citations